Almost as extensive as the SIPS study, blood from each patient is being used to examine the following:
- Genome
- Gene expression
- Metabolomics
- Proteomics
- Cytokines
By comparing patients to healthy blood relatives, we are more likely to understand what genes cause or contribute to the development of ME/CFS. This data will also be integrated with the SIPS data.